Harrow sells eye care medicines and compounded eye formulations to eyecare doctors and their patients. It last closed at $30.41 on Nov 20, down 5.35% on the day. The next earnings report for HROW is expected around Mon, Feb 1, 2027. For the quarter ended Sep 2026, HROW reported EPS of $0.25 on revenue of $99.3M, with revenue up 38.6% from a year ago. Over its last 8 reports the stock moved an average of 10.4% the session after earnings. Over the last 12 months HROW insiders bought $469K of stock on the open market and sold $9.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is HROW in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HROW.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on HROWStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
HROW · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock is 4% above its 20 day and 1% above its 50 day average. It is 22% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 53). The nearest support is the swing low (Sep 28) at $30.19, and the nearest resistance the Pivot at $31.05.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 6.0%/day
Key levels
$54.8552 week high+80.4%
$37.14200 day average+22.1%
$35.27100 day average+16.0%
$33.68Swing high (Nov 10)+10.8%
$31.79Pivot R1+4.5%
$31.05Pivot+2.1%
$30.41Last close
$30.19Swing low (Sep 28)−0.7%
$30.1450 day average−0.9%
$29.67Pivot S1−2.4%
$29.1520 day average−4.1%
$25.7652 week low−15.3%
Indicators
RSI (14)
52.60
Middle of its range
Neutral
MACD
0.22
Above its signal line
Bullish
Stochastic
73.3
Middle of its range
Neutral
ADX (14)
33.0
Trending up
Williams %R
-41.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
115.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+13.1%
Change over 10 sessions
Bullish
ATR (14)
$1.82
Typical daily range, 6.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 14.1%/day
Key levels
$54.8552 week high+80.4%
$37.14200 day average+22.1%
$35.27100 day average+16.0%
$33.68Swing high (Nov 10)+10.8%
$31.79Pivot R1+4.5%
$31.05Pivot+2.1%
$30.41Last close
$30.19Swing low (Sep 28)−0.7%
$30.1450 day average−0.9%
$29.67Pivot S1−2.4%
$29.1520 day average−4.1%
$25.7652 week low−15.3%
Indicators
RSI (14)
42.63
Middle of its range
Neutral
MACD
-2.92
Below its signal line
Bearish
Stochastic
19.8
Near the bottom of its range
Oversold
ADX (14)
16.8
No clear trend
Williams %R
-72.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
-59.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.8%
Change over 10 sessions
Bearish
ATR (14)
$4.29
Typical daily range, 14.1% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for HROW
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HROW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow HROW usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for HROWHow many large options trades hit HROW, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in HROW in the last 90 days.
From SEC Form 4 filings by HROW's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HROW is in one of them and how their past HROW trades turned out.
Harrow sells eye care medicines, mainly in the United States and Canada. Its branded portfolio includes eye drops and injections for conditions such as dry eye disease, pain after cataract surgery, bacterial eye infections, allergic itching and wet macular degeneration. The company also runs a compounding pharmacy business that supplies custom formulations. Its customers are eyecare doctors, surgeons and their patients. Harrow is based in Nashville, Tennessee.